NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
NAVCO Pharmaceuticals Inc., a company specializing in nanotechnology for health products, has granted 3.9 million stock options to its officers, directors, and consultants at $0.05 per share, exercisable over ten years. These options, part of the company’s 2018 stock option plan, vest immediately to aid in the growth of NAVCO, which is focused on innovative defenses against pathogens in various markets, including human health and veterinary services.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.